Literature DB >> 15718519

The treatment of lupus nephritis.

David P D'Cruz, Graham R V Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15718519      PMCID： PMC549098          DOI： 10.1136/bmj.330.7488.377

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Sequential therapies for proliferative lupus nephritis.

Authors:  Gabriel Contreras; Victoriano Pardo; Baudouin Leclercq; Oliver Lenz; Elaine Tozman; Patricia O'Nan; David Roth
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 2.  Ovarian failure and strategies for fertility preservation in patients with systemic lupus erythematosus.

Authors:  Amalia Raptopoulou; Prodromos Sidiropoulos; Dimitrios Boumpas
Journal:  Lupus       Date:  2004       Impact factor: 2.911

3.  Immunosuppressive therapy in lupus nephritis.

Authors:  D D'Cruz; M J Cuadrado; F Mujic; M F Tungekar; N Taub; M Lloyd; M A Khamashta; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1997 May-Jun       Impact factor: 4.473

4.  An open study of B lymphocyte depletion in systemic lupus erythematosus.

Authors:  Maria J Leandro; Jonathan C Edwards; Geraldine Cambridge; Michael R Ehrenstein; David A Isenberg
Journal:  Arthritis Rheum       Date:  2002-10

Review 5.  Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.

Authors:  M J Cuadrado; M A Khamashta; A Ballesteros; T Godfrey; M J Simon; G R Hughes
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

6.  Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.

Authors:  T M Chan; F K Li; C S Tang; R W Wong; G X Fang; Y L Ji; C S Lau; A K Wong; M K Tong; K W Chan; K N Lai
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

7.  Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension.

Authors:  S R Sangle; D P D'Cruz; W Jan; M Y Karim; M A Khamashta; I C Abbs; G R V Hughes
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

8.  Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

Authors:  Giovanni Sanna; Maria L Bertolaccini; Maria J Cuadrado; Hana Laing; Munther A Khamashta; Alessandro Mathieu; Graham R V Hughes
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

9.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Authors:  David Jayne; Niels Rasmussen; Konrad Andrassy; Paul Bacon; Jan Willem Cohen Tervaert; Jolanta Dadoniené; Agneta Ekstrand; Gill Gaskin; Gina Gregorini; Kirsten de Groot; Wolfgang Gross; E Christiaan Hagen; Eduardo Mirapeix; Erna Pettersson; Carl Siegert; Alberto Sinico; Vladimir Tesar; Kerstin Westman; Charles Pusey
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

Review 10.  The risk of pregnancy in patients with lupus nephritis.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902
View more
  1 in total

1.  Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative.

Authors:  Christos E Lampropoulos; Graham R V Hughes; David P D' Cruz
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.